ChromoGenics issue of new shares oversubscribed - brings in 117.3 MSEK and more than 2 000 new shareholders
ChromoGenics AB brings in 117.3 MSEK and more than 2 000 new shareholders through a now completed issue of new shares in combination with the company’s plan to list at Nasdaq First North Stockholm March 23rd 2017.The issue of new shares in ChromoGenics has been well received in the market and the board has decided to allocate about 119 MSEK, of which 117.3 MSEK correspond to the basic offer that will be added to ChromoGenics, before deduction of issue expenses and settlements of shareholder loans and guarantee fees. Excess amounts may be subject to normal market stabilization and / or